SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-19-019421
Filing Date
2019-12-19
Accepted
2019-12-18 18:16:43
Documents
4
Period of Report
2019-12-11
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 27637
2 logo_001.jpg GRAPHIC 6869
3 ex3-1.htm EX-3.1 1426
4 ex3-1_001.jpg GRAPHIC 149775
  Complete submission text file 0001493152-19-019421.txt   246360
Mailing Address 6320 CANOGA AVENUE 15TH FLOOR WOODLAND HILLS CA 91367
Business Address 6320 CANOGA AVENUE 15TH FLOOR WOODLAND HILLS CA 91367 (800) 489-4774
ENDONOVO THERAPEUTICS, INC. (Filer) CIK: 0001528172 (see all company filings)

IRS No.: 452552528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55453 | Film No.: 191293660
SIC: 2834 Pharmaceutical Preparations